Naveen Sharma, MD
Cardiology · Ventura, CANPI 1649387499
Payments from drug & device makers
Across 229 payments — averaging $49.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$5K
- Penumbra, Inc.$1K
- Aadi Bioscience, Inc.$800
- Amgen$582
- AstraZeneca$453
- Philips North America LLC$425
- plus $3K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 87 | $4,720 |
| Penumbra, Inc. | 4 | $1,031 |
| Aadi Bioscience, Inc. | 1 | $800 |
| Amgen(2 entities) | 14 | $582 |
| AstraZeneca | 9 | $453 |
| Philips North America LLC | 13 | $425 |
| Actelion Pharmaceuticals US, Inc. | 3 | $284 |
| Johnson & Johnson | 15 | $276 |
| Medtronic(2 entities) | 3 | $259 |
| Cardiovascular Systems Inc. | 9 | $255 |
| Edwards Lifesciences | 4 | $249 |
| Pfizer | 5 | $192 |
| Boston Scientific | 7 | $169 |
| AbbVie | 2 | $158 |
| Boehringer Ingelheim | 7 | $152 |
| Smith+Nephew | 2 | $146 |
| Bayer | 3 | $143 |
| Inspire Medical Systems, Inc. | 1 | $137 |
| Cordis US CORP. | 5 | $127 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| Novartis | 7 | $114 |
| Organogenesis Inc. | 1 | $114 |
| Novo Nordisk | 5 | $96 |
| E.r. Squibb & Sons, L.L.C. | 5 | $75 |
| Abbott | 3 | $63 |
| Alnylam Pharmaceuticals Inc. | 3 | $56 |
| Esperion Therapeutics, Inc. | 2 | $48 |
| Akcea Therapeutics, Inc. | 2 | $46 |
| Terumo Medical Corporation | 1 | $24 |
| Kowa Pharmaceuticals America, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $24 |
| Ascensia Diabetes Care US Inc. | 1 | $21 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $20 |
| Lantheus Medical Imaging, Inc. | 1 | $19 |
How this compares
$11,426 in reported general payments places this provider in the 85th percentile of 156 cardiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiology in Ventura
- Norman LeporBeverly Hills$7.1M
- Sanjay KaulLos Angeles$1.1M
- Mahmoud Eslami-FarsaniSanta Ana$410K
- Anil ShahSanta Ana$372K
- Ramtin AgahMountain View$361K
- David LangeSan Francisco$221K
- Jamshid MaddahiLos Angeles$147K
- Harpreet SinghFountain Valley$57K
- Bipin JoshiFresno$51K
- Robin StanInglewood$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.